A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease

Relja, Maja and Klepac, Nataša (2006) A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease. Journal of the Neurological Sciences, 248 (1-2). pp. 251-254. ISSN 0022-510X

Download (128kB) | Preview


The cognitive performance of 55 non-demented idiopathic Parkinson's disease (PD) patients treated with levodopa alone or receiving dopamine agonist pramipexole as add-on therapy to levodopa was evaluated in the present study during 6 months of treatment. Neuropsychological tests were administered two times. In the first assessment to differentiate test sensitive to cognitive changes typical for PD control group was also assessed. After 6 months of treatment PD patients were retested only with tests that differentiate them from control group. Compared to controls PD patients showed inferior performance on Stroop Interference test, Trail Making test, letter fluency and Hooper Visual Organization Test. No statistically significant differences between two groups and first and second neuropsychological assessment were found. Present findings indicate that pramipexole as add-on therapy to levodopa is safe in non-demented PD patients in terms of the effect on cognitive performance.

Item Type: Article
MeSH: Antiparkinson Agents - pharmacology - therapeutic use ; Benzothiazoles - pharmacology - therapeutic use ; Cognition - drug effects ; Parkinson Disease - drug therapy - physiopathology ; Adult ; Aged ; Case-Control Studies ; Female ; Follow-Up Studies ; Humans ; Levodopa - therapeutic use ; Male ; Middle Aged ; Neuropsychological Tests - statistics & numerical data
Departments: Katedra za neurologiju
Depositing User: Lea Škorić
Status: Published
Date: 25 October 2006
Date Deposited: 19 Mar 2007
Last Modified: 11 Nov 2019 08:05
Subjects: /
Related URLs:
URI: http://medlib.mef.hr/id/eprint/153

Actions (login required)

View Item View Item


Downloads per month over past year